Matches in Wikidata for { <http://www.wikidata.org/entity/Q58811079> ?p ?o ?g. }
Showing items 1 to 49 of
49
with 100 items per page.
- Q58811079 description "article scientifique publié en 2015" @default.
- Q58811079 description "artículu científicu espublizáu en payares de 2015" @default.
- Q58811079 description "im November 2015 veröffentlichter wissenschaftlicher Artikel" @default.
- Q58811079 description "scientific article published on 01 November 2015" @default.
- Q58811079 description "wetenschappelijk artikel" @default.
- Q58811079 description "наукова стаття, опублікована в листопаді 2015" @default.
- Q58811079 name "“Blindly” ADA Dose Escalation to 80 mg Weekly in Crohnʼs Disease Patients with LOR" @default.
- Q58811079 name "“Blindly” ADA Dose Escalation to 80 mg Weekly in Crohnʼs Disease Patients with LOR" @default.
- Q58811079 type Item @default.
- Q58811079 label "“Blindly” ADA Dose Escalation to 80 mg Weekly in Crohnʼs Disease Patients with LOR" @default.
- Q58811079 label "“Blindly” ADA Dose Escalation to 80 mg Weekly in Crohnʼs Disease Patients with LOR" @default.
- Q58811079 prefLabel "“Blindly” ADA Dose Escalation to 80 mg Weekly in Crohnʼs Disease Patients with LOR" @default.
- Q58811079 prefLabel "“Blindly” ADA Dose Escalation to 80 mg Weekly in Crohnʼs Disease Patients with LOR" @default.
- Q58811079 P1433 Q58811079-68491F06-0327-4154-BB49-B8D2C4D80015 @default.
- Q58811079 P1476 Q58811079-D34A3BF4-00DB-4A68-9C20-D700392262FE @default.
- Q58811079 P2093 Q58811079-2D1DBFC0-DDF8-496E-B524-81A5952E437F @default.
- Q58811079 P2093 Q58811079-87FD32A7-8FD1-42FA-B3CD-BC5A296B2328 @default.
- Q58811079 P2860 Q58811079-4F3E2981-8113-4031-A28A-8F492747144A @default.
- Q58811079 P2860 Q58811079-8EF049EE-61C3-4863-8344-E0132D032A52 @default.
- Q58811079 P2860 Q58811079-B56DA528-D6DC-4A9A-B48E-B7C712BDD8C3 @default.
- Q58811079 P2860 Q58811079-FBFED336-A303-4727-975A-DFAEADFFA04A @default.
- Q58811079 P304 Q58811079-3CA01E85-ABE4-4E50-BAF2-7218A10B1E8A @default.
- Q58811079 P31 Q58811079-03FEA148-2248-47FB-B70B-27942AAD33A1 @default.
- Q58811079 P356 Q58811079-734ED80C-BEA5-476E-845E-79538E815A8E @default.
- Q58811079 P433 Q58811079-8E9312A7-0271-4972-9B89-CF5AB60597C2 @default.
- Q58811079 P478 Q58811079-3A0A66BB-F903-46B6-9F01-0A14DE9A7EFD @default.
- Q58811079 P50 Q58811079-7AF5E7CC-3830-4938-82CE-EE150E7EB262 @default.
- Q58811079 P50 Q58811079-F16858C8-078C-4376-9A26-DB87B10E7D20 @default.
- Q58811079 P577 Q58811079-B0C8B014-58B8-4782-9597-8D480755A771 @default.
- Q58811079 P698 Q58811079-9A8D0F80-D154-43F0-A7B4-FFBB6778241F @default.
- Q58811079 P356 MIB.0000000000000604 @default.
- Q58811079 P698 26422520 @default.
- Q58811079 P1433 Q15749161 @default.
- Q58811079 P1476 ""Blindly" ADA Dose Escalation to 80 mg Weekly in Crohn's Disease Patients with LOR: Is It Cost Effective or Not?" @default.
- Q58811079 P2093 "Angela Bertani" @default.
- Q58811079 P2093 "Maria Di Girolamo" @default.
- Q58811079 P2860 Q38116299 @default.
- Q58811079 P2860 Q45083749 @default.
- Q58811079 P2860 Q53549600 @default.
- Q58811079 P2860 Q53572128 @default.
- Q58811079 P304 "E27-8" @default.
- Q58811079 P31 Q13442814 @default.
- Q58811079 P356 "10.1097/MIB.0000000000000604" @default.
- Q58811079 P433 "11" @default.
- Q58811079 P478 "21" @default.
- Q58811079 P50 Q42842723 @default.
- Q58811079 P50 Q51085349 @default.
- Q58811079 P577 "2015-11-01T00:00:00Z" @default.
- Q58811079 P698 "26422520" @default.